Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an …

Purpose of Review The introduction of the National Free Antiretroviral Therapy Program (NFATP)
in 2003 by the China National Center for AIDS/STD Control and Prevention has led to …

Background Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated
with disability and premature death. Up-to-date estimates of the burden of rheumatoid …

Before widespread vaccination programmes, potential side-effects and flares after COVID-19
vaccination were frequent reasons for vaccine hesitancy among people with rheumatic …

Objective We investigated prolonged COVID-19 symptom duration, defined as lasting 28
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs). …

Background HIV-related stigma among people living with HIV/AIDS (PLWHA) has been
associated with many negative consequences, including poor adherence to therapy and undue …

People ageing with HIV face crucial challenges that can compromise their long-term health,
one of which is stigma. HIV-related stigma can interact with other coexistent inequities to …

Introduction The Department of Veterans Affairs (VA) is the largest provider of HIV care in
the United States. Changes in healthcare delivery became necessary with the COVID‐19 …

High‐resolution peripheral quantitative computed tomography (HR‐pQCT) is an advanced
3D imaging technology that has the potential to contribute to fracture risk assessment and …